In addition, EPS8L2 expression level was increased in CRC samples with III and IV clinical stages (Fig. 1J) or lymph node metastasis (Fig. 1K and Supplementary Fig. 1B). This evidence concerns the gene EPS8L2 and colorectal carcinoma.